Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas
Viruses · 2025
DOI: 10.3390/v17030385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Ulrich A K Betz und 15 weiteren Autor:innen. Beteiligte Einrichtung: Merck KGaA, 64293 Darmstadt, Germany. Hauptthemen laut MEDLINE: Antiviral Agents, Drug Repositioning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck KGaA, Erling-Persson Foundation, Swedish Research Council.
Abstract (Originalsprache)
The pandemic threat from newly emerging viral diseases constitutes a major unsolved issue for global health. Antiviral therapy can play an important role in treating and preventing the spread of unprecedented viral infections. A repository of compounds exhibiting broad-spectrum antiviral activity against a series of different viral families would be an invaluable asset to be prepared for future pandemic threats. Utilizing an open innovation crowd-sourcing paradigm, we were able to identify a compound class of diphenylureas that exhibits in vitro antiviral activity against multiple viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), adenovirus, dengue virus, herpes, and influenza viruses. Compound 4 among the series exhibits strong activity against dengue virus, a growing global health problem with high medical need and no approved antiviral drug. The compounds are active against SARS-CoV-2 in a primary human stem cell-based mucociliary airway epithelium model and also active in vivo, as shown in a murine SARS-CoV-2 infection model. These results demonstrate the potential of the chemical class as antivirals on the one hand and the power of open innovation, crowd-sourcing, and repurposing on the other hand.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Merck KGaA, 64293 Darmstadt, Germany.
- EMD Serono Research & Development Institute, Inc., Billerica, MA 01821, USA.
- Merck Healthcare KGaA, 64293 Darmstadt, Germany.
- Calibr, The Scripps Research Institute, 11119 North Torrey Pines Road, La Jolla, CA 92037, USA.
- Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095, USA.
- Umeå Centre for Microbial Research, Umeå University, 901 87 Umeå, Sweden.
ORCID-Profile: Ulrich A K Betz, Norbert Beier, Robert Damoiseaux, Yongdae Gwon, Mikael Elofsson, Magnus Evander
Förderung
- Merck KGaA
- Erling-Persson Foundation
- Swedish Research Council
- Bill and Melinda Gates foundation
Zitieren
APA
Betz, U. A. K., Garces, R., Beier, N., Lindemann, S., Wolff, K. C., Riva, L., Kirkpatrick, M. G., Gebara-Lamb, A., McNamara, C. W., Damoiseaux, R., Gomperts, B. N., Arumugaswami, V., Strand, M., Gwon, Y., Elofsson, M., & Evander, M. (2025). Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas. Viruses. https://doi.org/10.3390/v17030385
Vancouver
Betz UAK, Garces R, Beier N, Lindemann S, Wolff KC, Riva L, et al. Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas. Viruses. 2025. doi:10.3390/v17030385
BibTeX
@article{Betz2025,
author = {Betz, Ulrich A K and Garces, Robert and Beier, Norbert and Lindemann, Sven and Wolff, Karen C and Riva, Laura and Kirkpatrick, Melanie G and Gebara-Lamb, Amal and McNamara, Case W and Damoiseaux, Robert and Gomperts, Brigitte N and Arumugaswami, Vaithilingaraja and Strand, Mårten and Gwon, Yongdae and Elofsson, Mikael and Evander, Magnus},
title = {Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17030385}
}
EUVIMED